4//SEC Filing
Grossi Federico 4
Accession 0000899243-22-034914
CIK 0001492422other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 4:27 PM ET
Size
4.8 KB
Accession
0000899243-22-034914
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Sale
Common Stock
2022-11-01$60.83/sh−2,500$152,075→ 99,884 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected by pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2022.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001720634
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 4:27 PM ET
- Size
- 4.8 KB